The third study that measured salivary NPs in CHF patients (NYHA III, reduced LVEF less than 40%) reported significantly higher saliva NT-proBNP levels in CHF patients compared to healthy controls, but failed to show an association between saliva and serum NT-proBNP levels in both groups [22]. The gene discussed is NPPB; the disease is congestive heart failure.